Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's disease

Recent news which mentions Alzheimer's disease

< Previous 1 2 3 Next >
Medicare details plan to cover Alzheimer's treatments
Tags U/S/ Economy Health care industry Alzheimer's disease
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Biotechnology Business Eisai Co Ltd
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Breaking News: Business Business News Coronavirus
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Health care industry Biotech and Pharmaceuticals Alzheimer's disease
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Breaking News: Business Business News Pharmaceuticals
From CNBC.com News
March 2023 Miscellany
Tags Alzheimer's Disease AC Immune (ACIU) Eli Lilly (LLY)
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags NervGen Pharma (NGEN/V NGENF) metformin Eisai (ESALY)
From Stock Gumshoe
Relevant Updates – December 2022
Tags Doc Gumshoe Alzheimer's Disease Moderna Therapeutics (MRNA)
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags MOR Benzinga why it's moving
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Longevity rates Nutrition Health Tips and Wellness Advice
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Penny Stocks Alzheimer's disease News
From Benzinga
Odd & Ends – October 2022
Tags Eli Lilly (LLY) Eisai (ESALY) Biogen Idec (BIIB)
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags RHHBY ABOS General
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Analyst Color Alzheimer's disease News
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags H/ Lundbeck (HLBBF HLUBF) diet Johnson and Johnson (JNJ)
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Health & Healthcare Quest Diagnostics NYSE:DGX
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags News Exclusives Alzheimer's disease
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags Doc Gumshoe Genting Berhad (GEBHY) Alzheimer's Disease
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags Market News ALEC Briefs
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Alzheimer's Disease Guest Articles TauRX Pharmaceuticals
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags Biotech Market News Aduhelm
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags Alzheimer's Disease Doc Gumshoe inflammation
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags News Alzheimer's disease Health Care
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags News Trading Ideas Alzheimer's disease
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags Biotech LGVN Phase 2 Trial
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Aduhelm Government Biotech
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags General Benzinga Phase 1 Trial
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags Market News ESALY Briefs
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags General News Alzheimer's disease
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Tickers PRTA
Tags General Benzinga Biotech
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.